-
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in the UK
Sep 9, 2025, 16:22 PM -
Retrospective Analysis of Carbapenem Antibiotic Use Expenditures and Market Patterns in Medicaid (1991-2023)
Sep 9, 2025, 16:22 PM -
Real-World Utilization Pattern of GLP-1 Receptor Agonists in German Outpatient Care
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Germany: A Return on Investment Analysis Using an Integrated Actuarial-Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia
Sep 9, 2025, 16:22 PM -
Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Previously Treated With First-Line (1L) Platinum-Based Chemotherapy (PBC)
Sep 9, 2025, 16:22 PM -
Estimating Costs Avoided by Preventing Recurrences With a BRCA Testing Strategy in High-Risk HER2-Negative Adjuvant Breast Cancer Patients in Spain
Sep 9, 2025, 16:22 PM -
Patient Characteristics and Treatment Comparison Among Patients With Chronic Obstructive Pulmonary Disease: Real-World Evidence From Sweden
Sep 9, 2025, 16:22 PM -
Impact of RSV Infection on Acute Otitis Media Burden in Young Children Beyond Their First Year of Life in Japan
Sep 9, 2025, 16:22 PM -
Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©
Sep 9, 2025, 16:22 PM -
Assessing Readiness for the EU-HTA Regulation: Insights From Market Access Experts Across Europe
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Amphotericin B Formulations for Invasive Fungal Disease in Hematologic Patients in China
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences
Sep 9, 2025, 16:22 PM -
How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?
Sep 9, 2025, 16:22 PM -
COVID-19 mRNA-1273 Vaccination in the UK: A Comparative Modeling Study of Alternative Eligibility Criteria
Sep 9, 2025, 16:22 PM -
Cost and Healthcare Resource Utilization Associated With Chronic Inducible Urticaria: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Clinical Burden and Complications Associated With Glycogen Storage Disease Type Ia (GSDIa): Results From a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Characteristics Associated With Having an Activity of Daily Living Limitation (ADLL) or Instrumental Activity of Daily Living Limitation (IADLL) Among US Adults With Asthma
Sep 9, 2025, 16:22 PM -
Review of Surrogate Endpoints’ Acceptance Trends in German HTA and Implications for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Impact of the 2022 NICE Methods Update on Patient Access to Advanced Cancer Treatments in England
Sep 9, 2025, 16:22 PM